Ausgabe 6/2011
Inhalt (6 Artikel)
Characterization of human pancreatic orthotopic tumor xenografts suitable for drug screening
Sandra Pérez-Torras, Anna Vidal-Pla, Rosa Miquel, Vanessa Almendro, Laureano Fernández-Cruz, Salvador Navarro, Joan Maurel, Neus Carbó, Pere Gascón, Adela Mazo
PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis
Arantza Fariña Sarasqueta, Eliane C. M. Zeestraten, Tom van Wezel, Gesina van Lijnschoten, Ronald van Eijk, Jan Willem T. Dekker, Peter J. K. Kuppen, Ines J. Goossens-Beumer, Valery E. P. P. Lemmens, Cornelis J. H. van de Velde, Harm J. T. Rutten, Hans Morreau, A. J. C. van den Brule
Aberrant promoter methylation and loss of Suppressor of Cytokine Signalling-1 gene expression in the development of uterine cervical carcinogenesis
R. C. Sobti, Neha Singh, Showket Hussain, Vanita Suri, Raje Nijhawan, A. C. Bharti, Mausumi Bharadwaj, B. C. Das
Gamma-secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myeloma
Feng Chen, Alexandra Pisklakova, Ming Li, Rachid Baz, Daniel M. Sullivan, Yulia Nefedova
Cervical carcinoma-associated fibroblasts are DNA diploid and do not show evidence for somatic genetic alterations
Willem Ernst Corver, Natalja Tatjana ter Haar, Gert Jan Fleuren, Jan Oosting
Subcellular FIH-1 expression patterns in invasive breast cancer in relation to HIF-1α expression
Agon Hyseni, Petra van der Groep, Elsken van der Wall, Paul J. van Diest